These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 16828206)

  • 1. Inflexal V--the influenza vaccine with the lowest ovalbumin content.
    Kürsteiner O; Moser C; Lazar H; Durrer P
    Vaccine; 2006 Nov; 24(44-46):6632-5. PubMed ID: 16828206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Large variations in the ovalbumin content in six European influenza vaccines.
    Mark C
    Pharmeur Sci Notes; 2006 Aug; 2006(1):27-9. PubMed ID: 17694643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eleven years of Inflexal V-a virosomal adjuvanted influenza vaccine.
    Herzog C; Hartmann K; Künzi V; Kürsteiner O; Mischler R; Lazar H; Glück R
    Vaccine; 2009 Jul; 27(33):4381-7. PubMed ID: 19450630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of flu vaccines with regard to their egg protein content.
    Goldis ME; Bardina L; Gimenez G; Lin J; Sampson HA
    Pediatr Allergy Immunol; 2011 Sep; 22(6):642-3. PubMed ID: 21919935
    [No Abstract]   [Full Text] [Related]  

  • 5. Safe administration of an inactivated virosomal adjuvanted influenza vaccine in asthmatic children with egg allergy.
    Esposito S; Gasparini C; Martelli A; Zenga A; Tremolati E; Varin E; Marseglia GL; Fiocchi A; Principi N
    Vaccine; 2008 Aug; 26(36):4664-8. PubMed ID: 18639601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Studies on sensitization after repeated topic application of live attenuated influenza vaccine (Gripovax) (author's transl)].
    Werner J; Kuwert EK
    Zentralbl Bakteriol Orig A; 1979 Jul; 244(2-3):144-54. PubMed ID: 315676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immediate adverse reactions after administration of the influenza vaccine to patients with positive CAP-RAST to egg white].
    Kawahara H; Morisawa Y; Katunuma T; Ohya Y; Saito H; Akasawa A
    Arerugi; 2002 Jul; 51(7):559-64. PubMed ID: 12201169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity and safety of low dose virosomal adjuvanted influenza vaccine administered intradermally compared to intramuscular full dose administration.
    Künzi V; Klap JM; Seiberling MK; Herzog C; Hartmann K; Kürsteiner O; Kompier R; Grimaldi R; Goudsmit J
    Vaccine; 2009 Jun; 27(27):3561-7. PubMed ID: 19464535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment of a highly sensitive sandwich enzyme-linked immunosorbent assay specific for ovomucoid from hen's egg white.
    Li Y; Song C; Zhang K; Wang M; Yang K; Yang A; Jin B
    J Agric Food Chem; 2008 Jan; 56(2):337-42. PubMed ID: 18163569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitizing activity to egg protein of an A1PO4-adjuvant full-virus influenza vaccine.
    Nyerges G; Marton A; Korossy S; Vincze I
    Acta Microbiol Acad Sci Hung; 1982; 29(4):245-53. PubMed ID: 7185267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Detection of ovalbumin in influenza vaccine by electrosyneresis].
    Barme M
    Dev Biol Stand; 1977 Jun 1-3; 39():213-7. PubMed ID: 604099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anaphylaxis from the influenza virus vaccine.
    Coop CA; Balanon SK; White KM; Whisman BA; Rathkopf MM
    Int Arch Allergy Immunol; 2008; 146(1):85-8. PubMed ID: 18087166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose response effects of avian influenza (H7N7) vaccination of chickens: serology, clinical protection and reduction of virus excretion.
    Maas R; Tacken M; van Zoelen D; Oei H
    Vaccine; 2009 Jun; 27(27):3592-7. PubMed ID: 19464539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ovalbumin content of 2010-2011 influenza vaccines.
    McKinney KK; Webb L; Petersen M; Nelson M; Laubach S
    J Allergy Clin Immunol; 2011 Jun; 127(6):1629-32. PubMed ID: 21397313
    [No Abstract]   [Full Text] [Related]  

  • 15. Intranasal delivery of whole influenza vaccine prevents subsequent allergen-induced sensitization and airway hyper-reactivity in mice.
    Minne A; Jaworska J; Gerhold K; Ahrens B; Avagyan A; Vanbever R; Matricardi PM; Schmidt AC; Hamelmann E
    Clin Exp Allergy; 2007 Aug; 37(8):1250-8. PubMed ID: 17651156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subunit influenza vaccines produced from cell culture or in embryonated chicken eggs: comparison of safety, reactogenicity, and immunogenicity.
    Reisinger KS; Block SL; Izu A; Groth N; Holmes SJ
    J Infect Dis; 2009 Sep; 200(6):849-57. PubMed ID: 19673652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of MDCK cells for production of live attenuated influenza vaccine.
    Liu J; Shi X; Schwartz R; Kemble G
    Vaccine; 2009 Oct; 27(46):6460-3. PubMed ID: 19559113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term immunogenicity of a virosomal subunit inactivated influenza vaccine in children with asthma.
    Zuccotti G; Amendola A; Viganò A; Pariani E; Zappa A; Pogliani L; Giacomet V; Savarino A; Podestà A; Rottoli A; Tanzi E; Zanetti A; Radaelli G
    Vaccine; 2007 Sep; 25(37-38):6692-8. PubMed ID: 17697730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Development of a novel influenza vaccine derived from a continuous cell line].
    Kistner O; Barrett N; Mundt W; Reiter M; Schober-Bendixen S; Eder G; Dorner F
    ALTEX; 2001; 18(1):50-4. PubMed ID: 11248852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a Vero cell-derived influenza whole virus vaccine.
    Kistner O; Barrett PN; Mundt W; Reiter M; Schober-Bendixen S; Eder G; Dorner F
    Dev Biol Stand; 1999; 98():101-10; discussion 111. PubMed ID: 10494963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.